Elçin Bakır
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Elçin Bakır has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
- Ayşe Eken
Erciyes Üniversitsi
6 shared publications - Burcu Ünlü Endirlik
Erciyes Universitesi
2 shared publications - Ahmet Cumaoğlu
Department of Biochemistry, Faculty of Pharmacy, Erciyes University, Kayseri, Türkiye
1 shared publication - Arzu Yay
Department of Histology and Embryology, Erciyes University, Kayseri 38039, Türkiye
1 shared publication - Aysun Ökçesiz Hacıseyitoğlu
Erciyes University
1 shared publication - Ayşe Baldemir Kılıç
SAĞLIK BİLİMLERİ ÜNİVERSİTESİ, GÜLHANE ECZACILIK FAKÜLTESİ, ECZACILIK MESLEK BİLİMLERİ BÖLÜMÜ, FARMASÖTİK BOTANİK ANABİLİM DALI
1 shared publication
Latest Publications
- 19 September 2026
- Published by Ankara Universitesi Eczacilik Fakultesi Dergisi in Ankara Universitesi Eczacilik Fakultesi Dergisi
- Vol. 50 (3) , 686-692
EVALUATION OF THE HEPATOPROTECTIVE EFFECTS OF VITAMIN E AND ALPHA-LIPOIC ACID AGAINST DIMETHOATE TOXICITY IN VITRO
Objective: In this study, the protective effects of vitamin E (Vit E) and alpha-lipoic acid (LA) against the hepatotoxicity of dimethoate, a widely used organophosphate pesticide, were investigated.Material and Method: The 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) test was applied to evaluate cell viability at 24 and 48 hours. The dichlorofluorescein diacetate test was used to evaluate reactive oxygen species (ROS) formation.Result and Discussion: Half maximum inhibitory concentration (IC50) values were calculated as 412 µM and 181 µM for 24 and 48 h, respectively. Dimethoate significantly decreased cell viability in HepG2 cells at 250 µM for 24 hours of exposure and at 50 µM for 48 hours of exposure. Cell viability decreased in a dose-dependent manner. Vit E was observed to increase cell viability significantly at 250 µM concentration (p<0.05) at 24 h. On the other hand, according to the 48-hour exposure results, Vit E was found to be protective against 100 and 250 µM dimethoate (p<0.01). Furthermore, at 4 h exposure, Vit E and LA significantly decreased the ROS levels induced by 100 µM dimethoate treatment (p<0.05 and p<0.001, respectively). In 24 h exposure, it was observed that only Vit E significantly decreased (p<0.05) the ROS levels formed by 100 µM and 250 µM dimethoate treatment. The findings showed that Vit E could be a hepatoprotective agent against possible dimethoate toxicity.
- 19 September 2026
- Published by Ankara Universitesi Eczacilik Fakultesi Dergisi in Ankara Universitesi Eczacilik Fakultesi Dergisi
- Vol. 50 (3) , 686-692
EVALUATION OF THE HEPATOPROTECTIVE EFFECTS OF VITAMIN E AND ALPHA-LIPOIC ACID AGAINST DIMETHOATE TOXICITY IN VITRO
Objective: In this study, the protective effects of vitamin E (Vit E) and alpha-lipoic acid (LA) against the hepatotoxicity of dimethoate, a widely used organophosphate pesticide, were investigated.Material and Method: The 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) test was applied to evaluate cell viability at 24 and 48 hours. The dichlorofluorescein diacetate test was used to evaluate reactive oxygen species (ROS) formation.Result and Discussion: Half maximum inhibitory concentration (IC50) values were calculated as 412 µM and 181 µM for 24 and 48 h, respectively. Dimethoate significantly decreased cell viability in HepG2 cells at 250 µM for 24 hours of exposure and at 50 µM for 48 hours of exposure. Cell viability decreased in a dose-dependent manner. Vit E was observed to increase cell viability significantly at 250 µM concentration (p<0.05) at 24 h. On the other hand, according to the 48-hour exposure results, Vit E was found to be protective against 100 and 250 µM dimethoate (p<0.01). Furthermore, at 4 h exposure, Vit E and LA significantly decreased the ROS levels induced by 100 µM dimethoate treatment (p<0.05 and p<0.001, respectively). In 24 h exposure, it was observed that only Vit E significantly decreased (p<0.05) the ROS levels formed by 100 µM and 250 µM dimethoate treatment. The findings showed that Vit E could be a hepatoprotective agent against possible dimethoate toxicity.
- 1 April 2024
- Published by Erciyes Universitesi (DergiPark) in Sağlık Bilimleri Dergisi
- Vol. 33 (1) , 60-66
ANTIPROLIFERATIVE AND ANTIOXIDANT EFFECTS OF CARNOSIC ACID ON HUMAN LIVER CANCER CELLS
The purpose of the study was to investigate the cytotoxic effects of carnosic acid alone and in combination with cisplatin on human liver cancer cells and their capacity to scavenge reactive oxygen species induced in the presence or absence of hydrogen peroxide.Cytotoxic effects of agents on human liver cancer cells for 24 and 48 hours were evaluated by methyl-thiazol tetrazolium-bromide assay. Mitochondrial membrane potential were detected JC-1 kit. The intracellular reactive oxygen species levels were determined using 2’-7’dichlorofluorescin diacetateassay. According to our findings, both carnosic acid alone and in combination with cisplatin showed cytotoxic effects in human liver cancer cells at 24 and 48 hours of exposure. In particular, it was seen that the cell viability significantly decreased in a dose-dependent manner at 48 hours of exposure, and the combined treatment was found to have a more pronounced cytotoxic effect. In addition, all carnosic acid concentrations alone and in combination with cisplatin were identified to significantly reduce mitochondrial membrane potential. We observed that both carnosic acid alone and in combination with cisplatin lowered intracellular reactive oxygen species levels in the presence or absence of hydrogen peroxide. The results suggested that carnosic acid alone or in combination with cisplatin might be a promising agent in the treatment of liver cancer.
- 1 April 2024
- Published by Erciyes Universitesi (DergiPark) in Sağlık Bilimleri Dergisi
- Vol. 33 (1) , 60-66
ANTIPROLIFERATIVE AND ANTIOXIDANT EFFECTS OF CARNOSIC ACID ON HUMAN LIVER CANCER CELLS
The purpose of the study was to investigate the cytotoxic effects of carnosic acid alone and in combination with cisplatin on human liver cancer cells and their capacity to scavenge reactive oxygen species induced in the presence or absence of hydrogen peroxide.Cytotoxic effects of agents on human liver cancer cells for 24 and 48 hours were evaluated by methyl-thiazol tetrazolium-bromide assay. Mitochondrial membrane potential were detected JC-1 kit. The intracellular reactive oxygen species levels were determined using 2’-7’dichlorofluorescin diacetateassay. According to our findings, both carnosic acid alone and in combination with cisplatin showed cytotoxic effects in human liver cancer cells at 24 and 48 hours of exposure. In particular, it was seen that the cell viability significantly decreased in a dose-dependent manner at 48 hours of exposure, and the combined treatment was found to have a more pronounced cytotoxic effect. In addition, all carnosic acid concentrations alone and in combination with cisplatin were identified to significantly reduce mitochondrial membrane potential. We observed that both carnosic acid alone and in combination with cisplatin lowered intracellular reactive oxygen species levels in the presence or absence of hydrogen peroxide. The results suggested that carnosic acid alone or in combination with cisplatin might be a promising agent in the treatment of liver cancer.
- Open Access
- 26 April 2023
- Published by Joint Diseases and Related Surgery in Joint Diseases and Related Surgery
- Vol. 34 (2) , 346-355
Hydroxychloroquine induces oxidative stress and impairs fracture healing in rats
Joint Diseases and Related Surgery (JDRS), the official journal of the Turkish Joint Diseases Foundation, is an international, peer-reviewed, immediate open access journal. All published articles in JDRS has been free for everyone, without embargo, since 1990.
- 26 April 2023
- Published by Joint Diseases and Related Surgery in Joint Diseases and Related Surgery
- Vol. 34 (2) , 346-355
Open AccessHydroxychloroquine induces oxidative stress and impairs fracture healing in rats
Joint Diseases and Related Surgery (JDRS), the official journal of the Turkish Joint Diseases Foundation, is an international, peer-reviewed, immediate open access journal. All published articles in JDRS has been free for everyone, without embargo, since 1990.
- 31 December 2022
- Published by FABAD Farmasotik Bilimler Ankara Dernegi in Fabad Journal of Pharmaceutical Sciences
Investigation of Dimethoate Toxicity in Rat Brain and Protective Effect of Laurocerasus officinalis Roem. Fruit Extract Against Oxidative Stress, DNA Damage and Apoptosis
Dimethoate is an organophosphate insecticide which is used globally in a wide scale in agriculture. It was associated with numerous negative health effects in many studies. Brain is one of the target organs for dimethoate exposure. The aim of present study was to evaluate sub-chronic (60 days) toxicity of dimethoate (7 mg/kg b.w.), investigating its oxidative stress, DNA damage, as well as apoptosis inducing effects, and histopathological changes in brain tissue of rats. We also aimed to analyze protective effects of Laurocerasus officinalis Roem. (cherry laurel) fruit extract. To evaluate oxidative stress, malondialdehyde (MDA) levels, as well as superoxide dismutase (Cu-Zn SOD), glutathione peroxidase (GPx) and catalase (CAT) antioxidant enzymes activities were calculated. Experimental results demonstrated that dimethoate treatment increased MDA and depleted Cu-Zn SOD, GPx and CAT enzyme activities, suggesting its potency as an oxidative stress inducer in rat brain tissues. Furthermore, comet and TUNEL assay results showed that dimethoate stimulated DNA damage and apoptosis. Administration of cherry laurel extract protected against dimethoate-induced oxidative stress, DNA damage and apoptosis. Findings of currents study are important in terms of demonstrating the beneficial effects of L. officinalis extract against dimethoate toxicity in brain, considering the sensitivity of this organ to oxidative stress and extensive usage of dimethoate.
- 31 December 2022
- Published by FABAD Farmasotik Bilimler Ankara Dernegi in Fabad Journal of Pharmaceutical Sciences
Investigation of Dimethoate Toxicity in Rat Brain and Protective Effect of Laurocerasus officinalis Roem. Fruit Extract Against Oxidative Stress, DNA Damage and Apoptosis
Dimethoate is an organophosphate insecticide which is used globally in a wide scale in agriculture. It was associated with numerous negative health effects in many studies. Brain is one of the target organs for dimethoate exposure. The aim of present study was to evaluate sub-chronic (60 days) toxicity of dimethoate (7 mg/kg b.w.), investigating its oxidative stress, DNA damage, as well as apoptosis inducing effects, and histopathological changes in brain tissue of rats. We also aimed to analyze protective effects of Laurocerasus officinalis Roem. (cherry laurel) fruit extract. To evaluate oxidative stress, malondialdehyde (MDA) levels, as well as superoxide dismutase (Cu-Zn SOD), glutathione peroxidase (GPx) and catalase (CAT) antioxidant enzymes activities were calculated. Experimental results demonstrated that dimethoate treatment increased MDA and depleted Cu-Zn SOD, GPx and CAT enzyme activities, suggesting its potency as an oxidative stress inducer in rat brain tissues. Furthermore, comet and TUNEL assay results showed that dimethoate stimulated DNA damage and apoptosis. Administration of cherry laurel extract protected against dimethoate-induced oxidative stress, DNA damage and apoptosis. Findings of currents study are important in terms of demonstrating the beneficial effects of L. officinalis extract against dimethoate toxicity in brain, considering the sensitivity of this organ to oxidative stress and extensive usage of dimethoate.
- 30 August 2021
- Published by Wiley in Journal of Biochemical and Molecular Toxicology
- Vol. 35 (11) , e22905
Doxazosin and erlotinib have anticancer effects in the endometrial cancer cell and important roles in ERα and Wnt/β‐catenin signaling pathways
ERα and Wnt/β‐catenin pathways are critical for the progression of most endometrial cancers. We aimed to investigate the cytotoxic and apoptotic effects of tamoxifen and quinazoline derivative drugs of doxazosin and erlotinib, and their roles in ERα and Wnt/β‐catenin signaling pathways in human endometrial cancer RL 95‐2 cell. 3‐(4,5‐Dimethylthiazol‐2yl)−2,5‐diphenyltetrazolium bromide assay and xCELLigence systems were performed to evaluate cytotoxicity. Furthermore, apoptotic induction was tested by Annexin V analysis. Caspase‐3 and ‐9 activity and changes in the mitochondrial membrane potential were evaluated. The level of reactive oxygen species was measured by incubating with dichlorofluorescein diacetate. Protein ratios of p‐ERα/ERα, GSK3β/p‐GSK3β, and p‐β‐catenin/β‐catenin and expression levels of ESR1, EGFR, c‐Myc genes were evaluated to elucidate mechanisms in signaling pathways. We found that the tested drugs showed cytotoxic and apoptotic effects in the cells. Doxazosin significantly reduced ESR1 expression, slightly reduced the p‐β‐catenin/β‐catenin ratio and c‐Myc expression. Erlotinib significantly increased c‐Myc expression while significantly decreasing the p‐β‐catenin/β‐catenin and p‐ERα/ERα ratio, and ESR1 expression. However, we observed that the cells develop resistance to erlotinib over a certain concentration, suggesting that ERα, ESR1, EGFR, and c‐Myc may be a new target for overcoming drug resistance in the treatment of endometrial cancer. We also observed that erlotinib and doxazosin play an important role in the ERα signaling pathway and can act as potent inhibitors of PKA and/or tyrosine kinase in the Wnt/β‐catenin signaling pathway in RL 95‐2 cell. In conclusion, doxazosin and erlotinib may have a possible therapeutic potential in human endometrial cancer.
- 30 August 2021
- Published by Wiley in Journal of Biochemical and Molecular Toxicology
- Vol. 35 (11) , e22905
Doxazosin and erlotinib have anticancer effects in the endometrial cancer cell and important roles in ERα and Wnt/β‐catenin signaling pathways
ERα and Wnt/β‐catenin pathways are critical for the progression of most endometrial cancers. We aimed to investigate the cytotoxic and apoptotic effects of tamoxifen and quinazoline derivative drugs of doxazosin and erlotinib, and their roles in ERα and Wnt/β‐catenin signaling pathways in human endometrial cancer RL 95‐2 cell. 3‐(4,5‐Dimethylthiazol‐2yl)−2,5‐diphenyltetrazolium bromide assay and xCELLigence systems were performed to evaluate cytotoxicity. Furthermore, apoptotic induction was tested by Annexin V analysis. Caspase‐3 and ‐9 activity and changes in the mitochondrial membrane potential were evaluated. The level of reactive oxygen species was measured by incubating with dichlorofluorescein diacetate. Protein ratios of p‐ERα/ERα, GSK3β/p‐GSK3β, and p‐β‐catenin/β‐catenin and expression levels of ESR1, EGFR, c‐Myc genes were evaluated to elucidate mechanisms in signaling pathways. We found that the tested drugs showed cytotoxic and apoptotic effects in the cells. Doxazosin significantly reduced ESR1 expression, slightly reduced the p‐β‐catenin/β‐catenin ratio and c‐Myc expression. Erlotinib significantly increased c‐Myc expression while significantly decreasing the p‐β‐catenin/β‐catenin and p‐ERα/ERα ratio, and ESR1 expression. However, we observed that the cells develop resistance to erlotinib over a certain concentration, suggesting that ERα, ESR1, EGFR, and c‐Myc may be a new target for overcoming drug resistance in the treatment of endometrial cancer. We also observed that erlotinib and doxazosin play an important role in the ERα signaling pathway and can act as potent inhibitors of PKA and/or tyrosine kinase in the Wnt/β‐catenin signaling pathway in RL 95‐2 cell. In conclusion, doxazosin and erlotinib may have a possible therapeutic potential in human endometrial cancer.
- 11 March 2021
- Published by Wiley in Journal of Biochemical and Molecular Toxicology
- Vol. 35 (6) , 1-11
Assessment of the cytotoxic, genotoxic, and apoptotic potential of flurbiprofen in HeLa and HepG2 cell lines
In the literature, the anticancer potential of flurbiprofen isn't fully understood. In this study, the cytotoxic, genotoxic, and apoptotic effects of flurbiprofen were evaluated in human cervical and liver cancer cells. Cytotoxicity was measured by 3‐(4,5‐dimethylthiazol‐2‐yl)‐2,5‐diphenyltetrazolium bromide assay, and it was observed that cytotoxicity increased in a concentration‐ and time‐dependent manner. Genotoxicity was determined using alkaline Comet assay. DNA damage increased in a concentration‐dependent manner. Early apoptosis was evaluated using real‐time polymerase chain reaction, and it was found that apoptotic gene levels increased while antiapoptotic gene levels decreased. Late apoptosis and cell cycle analyzes were determined using flow cytometry. No evidence of late apoptosis was observed, and no significant arrest was found in the cell cycle. In conclusion, it seems that flurbiprofen has a cytotoxic, genotoxic, and apoptotic effects in both human cancer cell lines. Moreover, the findings indicate that flurbiprofen is effective at the gene level and induces apoptosis with an intracellular pathway.
- 11 March 2021
- Published by Wiley in Journal of Biochemical and Molecular Toxicology
- Vol. 35 (6) , 1-11
Assessment of the cytotoxic, genotoxic, and apoptotic potential of flurbiprofen in HeLa and HepG2 cell lines
In the literature, the anticancer potential of flurbiprofen isn't fully understood. In this study, the cytotoxic, genotoxic, and apoptotic effects of flurbiprofen were evaluated in human cervical and liver cancer cells. Cytotoxicity was measured by 3‐(4,5‐dimethylthiazol‐2‐yl)‐2,5‐diphenyltetrazolium bromide assay, and it was observed that cytotoxicity increased in a concentration‐ and time‐dependent manner. Genotoxicity was determined using alkaline Comet assay. DNA damage increased in a concentration‐dependent manner. Early apoptosis was evaluated using real‐time polymerase chain reaction, and it was found that apoptotic gene levels increased while antiapoptotic gene levels decreased. Late apoptosis and cell cycle analyzes were determined using flow cytometry. No evidence of late apoptosis was observed, and no significant arrest was found in the cell cycle. In conclusion, it seems that flurbiprofen has a cytotoxic, genotoxic, and apoptotic effects in both human cancer cell lines. Moreover, the findings indicate that flurbiprofen is effective at the gene level and induces apoptosis with an intracellular pathway.